Wyeth Gets Federal Backing In Preemption Case

Law360 (June 6, 2008, 12:00 AM EDT) -- The federal government has thrown its support behind Wyeth Pharmaceuticals Inc. in the U.S. Supreme Court case over whether the Food and Drug Administration’s approval of a drug preempts state-law product liability claims.

The FDA’s decision to approve a drug and its labeling reflects the agency’s expert evaluation of the health risks and benefits the product can provide, Solicitor General Paul Clement said in an amicus brief filed on Thursday.

“Respondent’s claims are preempted because they challenge labeling that FDA approved after being informed of the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.